BeStock  
Markets › Compare › ERAS vs BLTE

ERAS vs BLTE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ERAS · Erasca$13.61 ▼ 4.29%
BLTE · Belite Bio$127.38 ▼ 15.65%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

53244436627819Nov 24, '25May 26, '26Nov 20, '26
  • ERAS +370.9%
  • BLTE -6.3%

Head to head

MetricERASBLTE
Price$13.61$127.38
Change today▼ 4.29%▼ 15.65%
Market cap$4.78B$5.17B
Return, 3 months-22.7%-19.8%
Return, year to date+265.9%-20.4%
Return, 1 year+366.1%+5.7%
P/E (TTM)––
P/B5.26.7
P/E percentile vs own 5y12th40th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-67.7%-39.6%
Gross margin––
Operating margin––
Net margin––
Return on equity-48.7%-21.2%
Analyst target vs. price+81.3%+81.9%
Analyst buy share67%100%
RSI (14)4332
30-day volatility81.2%74.4%
Max drawdown, 1 year-59.5%-34.2%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BLTE is the largest of the group by market value.
  • ERAS has returned the most over the past year.
  • BLTE has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top